MGP
Metis Global Partners’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,720
| Closed | -$318K | – | 793 |
|
|
2024
Q4 | $318K | Buy |
1,720
+72
| +4% | +$13.3K | 0.01% | 656 |
|
|
2024
Q3 | $325K | Buy |
1,648
+21
| +1% | +$4.14K | 0.01% | 656 |
|
|
2024
Q2 | $336K | Sell |
1,627
-8
| -0.5% | -$1.65K | 0.01% | 636 |
|
|
2024
Q1 | $443K | Sell |
1,635
-24
| -1% | -$6.5K | 0.02% | 580 |
|
|
2023
Q4 | $392K | Sell |
1,659
-209
| -11% | -$49.4K | 0.02% | 598 |
|
|
2023
Q3 | $366K | Buy |
1,868
+346
| +23% | +$67.8K | 0.02% | 602 |
|
|
2023
Q2 | $320K | Sell |
1,522
-40
| -3% | -$8.41K | 0.02% | 609 |
|
|
2023
Q1 | $315K | Buy |
1,562
+505
| +48% | +$102K | 0.02% | 584 |
|
|
2022
Q4 | $230K | Buy |
+1,057
| New | +$230K | 0.02% | 578 |
|
|
2022
Q2 | – | Sell |
-799
| Closed | -$227K | – | 544 |
|
|
2022
Q1 | $227K | Buy |
+799
| New | +$227K | 0.03% | 507 |
|